These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14182036)

  • 1. SYSTEMIC LUPUS ERYTHEMATOSUS: THE FAILURE OF URINALYSIS AND SIMPLE RENAL FUNCTION TESTS TO PREDICT RELIABLY THE UNDERLYING RENAL PATHOLOGY.
    POLLAK VE; SCHWARTZ FD; PIRANI CL
    Presbyt St Lukes Hosp Med Bull; 1964 Jul; 3():94-103. PubMed ID: 14182036
    [No Abstract]   [Full Text] [Related]  

  • 2. Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus.
    Epstein WV; Grausz H
    Arthritis Rheum; 1974; 17(2):129-42. PubMed ID: 4131150
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolated pyuria in systemic lupus erythematosus.
    Appenzeller S; Clark A; Pineau C; Vasilevsky M; Bernatsky S
    Lupus; 2010 Jun; 19(7):793-6. PubMed ID: 20305045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREATMENT OF THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS.
    POLLAK VE
    Mod Treat; 1964 Jan; 1():89-99. PubMed ID: 14161719
    [No Abstract]   [Full Text] [Related]  

  • 5. Can the urine dipstick test reduce the need for microscopy for assessment of systemic lupus erythematosus disease activity?
    Chan RW; Chow KM; Tam LS; Li EK; Wong SM; Li PK; Szeto CC
    J Rheumatol; 2005 May; 32(5):828-31. PubMed ID: 15868617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.
    POLLAK VE; PIRANI CL; SCHWARTZ FD
    J Lab Clin Med; 1964 Apr; 63():537-50. PubMed ID: 14155443
    [No Abstract]   [Full Text] [Related]  

  • 7. STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS.
    LANGE K; ORES R; STRAUSS W; WACHSTEIN M
    Arthritis Rheum; 1965 Apr; 8():244-59. PubMed ID: 14280256
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity.
    Ding JY; Ibañez D; Gladman DD; Urowitz MB
    J Rheumatol; 2015 Mar; 42(3):437-40. PubMed ID: 25593226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
    Eicken S; Gugger M; Marti HP
    Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.
    JOACHIM GR; CAMERON JS; SCHWARTZ M; BECKER EL
    J Clin Invest; 1964 Dec; 43(12):2332-46. PubMed ID: 14234829
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus.
    Rahman P; Gladman DD; Ibanez D; Urowitz MB
    Lupus; 2001; 10(6):418-23. PubMed ID: 11434577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LUPUS GLOMERULONEPHRITIS. THE EFFECT OF LARGE DOSES OF CORTICOSTEROIDS ON RENAL FUNCTION AND RENAL LESIONS IN TWO CHILDREN.
    SMITH FG; LITMAN N; LATTA H
    Am J Dis Child; 1965 Sep; 110():302-8. PubMed ID: 14332367
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare.
    Ayoub I; Birmingham D; Rovin B; Hebert L
    Curr Rheumatol Rep; 2019 Feb; 21(4):12. PubMed ID: 30810824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells.
    Hamadah AM; Gharaibeh K; Mara KC; Thompson KA; Lieske JC; Said S; Nasr SH; Leung N
    Nephrol Dial Transplant; 2018 Aug; 33(8):1397-1403. PubMed ID: 29156008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide in lupus nephritis: a controlled trial.
    Steinberg AD; Kaltreider HB; Staples PJ; Goetzl EJ; Talal N; Decker JL
    Ann Intern Med; 1971 Aug; 75(2):165-71. PubMed ID: 4104337
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertension and renal disease in systemic lupus erythematosus.
    Budman DR; Steinberg AD
    Arch Intern Med; 1976 Sep; 136(9):1003-7. PubMed ID: 962443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus.
    Hebert LA; Dillon JJ; Middendorf DF; Lewis EJ; Peter JB
    Am J Kidney Dis; 1995 Sep; 26(3):432-8. PubMed ID: 7645551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 19. Transformation of diffuse proliferative glomerulonephritis to membranous nephritis in a patient with systemic lupus erythematosus.
    Hall-Craggs M; Ramos E
    Nephron; 1981; 28(1):42-5. PubMed ID: 7266728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal manifestations of drug-induced systemic lupus erythematosus.
    Sheikh TK; Charron RC; Katz A
    Am J Clin Pathol; 1981 May; 75(5):755-62. PubMed ID: 7015825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.